letrozole and imatinib mesylate

letrozole has been researched along with imatinib mesylate in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Kaplow, R	1
Chow, LW; Loo, WT; Toi, M; Yip, AY	1
Arun, B; Bast, RC; Booser, DJ; Brewster, AM; Esteva, FJ; Giordano, SH; Hortobagyi, GN; Moulder, SL; Murray, JL; Murthy, RK; Rauch, GM; Valero, V; Walters, RS; Yam, C; Yang, W	1
Al Hussein Al Awamlh, B; Barocas, DA; Chang, SS; Cortese, BD; Dusetzina, SB; Luckenbaugh, AN; Penson, DF; Stimson, CJ; Talwar, R	1

Reviews

1 review(s) available for letrozole and imatinib mesylate

Article	Year
Innovations in antineoplastic therapy. The Nursing clinics of North America, 2005, Volume: 40, Issue:1 Topics: Adjuvants, Immunologic; Alemtuzumab; Aminoglycosides; Anastrozole; Androstadienes; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Benzamides; Bile; Boronic Acids; Bortezomib; Capecitabine; Cetuximab; Decanoic Acids; Deoxycytidine; Docetaxel; Drug Approval; Estradiol; Fluorouracil; Fulvestrant; Gefitinib; Gemtuzumab; Humans; Imatinib Mesylate; Letrozole; Leuprolide; Nitriles; Oligopeptides; Organoplatinum Compounds; Oxaliplatin; Oxides; Piperazines; Polyesters; Pyrazines; Pyrimidines; Quinazolines; Taxoids; Thionucleotides; Tissue Extracts; Triazoles; United States; United States Food and Drug Administration; Vidarabine Phosphate	2005

Article

Year

Innovations in antineoplastic therapy.

The Nursing clinics of North America, 2005, Volume: 40, Issue:1

Topics: Adjuvants, Immunologic; Alemtuzumab; Aminoglycosides; Anastrozole; Androstadienes; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Benzamides; Bile; Boronic Acids; Bortezomib; Capecitabine; Cetuximab; Decanoic Acids; Deoxycytidine; Docetaxel; Drug Approval; Estradiol; Fluorouracil; Fulvestrant; Gefitinib; Gemtuzumab; Humans; Imatinib Mesylate; Letrozole; Leuprolide; Nitriles; Oligopeptides; Organoplatinum Compounds; Oxaliplatin; Oxides; Piperazines; Polyesters; Pyrazines; Pyrimidines; Quinazolines; Taxoids; Thionucleotides; Tissue Extracts; Triazoles; United States; United States Food and Drug Administration; Vidarabine Phosphate

2005

Trials

2 trial(s) available for letrozole and imatinib mesylate

Article	Year
Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer. Cancer letters, 2008, Apr-18, Volume: 262, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Benzamides; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Drug Evaluation; Female; Humans; Imatinib Mesylate; Letrozole; Middle Aged; Neoadjuvant Therapy; Neoplasms, Hormone-Dependent; Nitriles; Pilot Projects; Piperazines; Postmenopause; Pyrimidines; Signal Transduction; Triazoles	2008
A phase II study of imatinib mesylate and letrozole in patients with hormone receptor-positive metastatic breast cancer expressing c-kit or PDGFR-β. Investigational new drugs, 2018, Volume: 36, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Letrozole; Middle Aged; Neoplasm Metastasis; Progression-Free Survival; Proto-Oncogene Proteins c-kit; Receptor, Platelet-Derived Growth Factor beta; Treatment Outcome	2018

Article

Year

Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer.

Cancer letters, 2008, Apr-18, Volume: 262, Issue:2

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Benzamides; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Drug Evaluation; Female; Humans; Imatinib Mesylate; Letrozole; Middle Aged; Neoadjuvant Therapy; Neoplasms, Hormone-Dependent; Nitriles; Pilot Projects; Piperazines; Postmenopause; Pyrimidines; Signal Transduction; Triazoles

2008

A phase II study of imatinib mesylate and letrozole in patients with hormone receptor-positive metastatic breast cancer expressing c-kit or PDGFR-β.

Investigational new drugs, 2018, Volume: 36, Issue:6

Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Letrozole; Middle Aged; Neoplasm Metastasis; Progression-Free Survival; Proto-Oncogene Proteins c-kit; Receptor, Platelet-Derived Growth Factor beta; Treatment Outcome

2018

Other Studies

1 other study(ies) available for letrozole and imatinib mesylate

Article	Year
Projected Savings for Generic Oncology Drugs Purchased via Mark Cuban Cost Plus Drug Company Versus in Medicare. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023, 10-10, Volume: 41, Issue:29 Topics: Aged; Anastrozole; Cost Savings; Drug Costs; Drugs, Generic; Humans; Imatinib Mesylate; Letrozole; Medicare Part D; Prescription Drugs; Tamoxifen; United States	2023

Article

Year

Projected Savings for Generic Oncology Drugs Purchased via Mark Cuban Cost Plus Drug Company Versus in Medicare.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023, 10-10, Volume: 41, Issue:29

Topics: Aged; Anastrozole; Cost Savings; Drug Costs; Drugs, Generic; Humans; Imatinib Mesylate; Letrozole; Medicare Part D; Prescription Drugs; Tamoxifen; United States

2023